Skip to main content
Figure 2 | Trials

Figure 2

From: Implementation of a publication strategy in the context of reporting biases. A case study based on new documents from Neurontin® litigation

Figure 2

Key messages for inclusion in publications appeared to have been developed based on a branding guide. Excerpt from internal company minutes of meeting with Medical Action Communications (MAC) and the Neurontin Publication Sub-committee (NTN PSC) dated July 18, 2011. The document illustrates how “key messages” appeared to have been developed by MAC based on a branding guide for gabapentin. Excerpted from Pfizer_RGlanzmann_0044636 [29].

Back to article page